ClinicalTrials.gg
Drug

Entecavir clinical trials

Also written Baraclude, BMS-200475 and Baraclude 0.5mg.

Includes 1 study of Entecavir maleate.

studies test it
104
open now
7
in phase 3
20
first study started
2001

How each study uses entecavir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the entecavir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Mar 2005 · BARACLUDE · NDA 021797 (FDA, Drugs@FDA)
European Union
26 Jun 2006 · Baraclude · EMEA/H/C/000623 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Entecavir
76
ETV
5
Entecavir prophylaxis
3
Entecavir Dispersible Tablets
3
Entecavir (Baraclude)
2

Brand

Baraclude
37
Baraclude 0.5mg
3
Baraclude 1.0mg
1

Development codes

BMS-200475
15

In one entry with another drug

Given together, or one or the other

Entecavir + Tenofovir
2
Entecavir, Adefovir
2

Studies by the year they started

104 studies that test it; most in 2008 (12)

Studies that test entecavir, by start year
YearStudies
20013
20023
20034
20042
20062
20078
200812
20095
20106
20112
20127
201310
20145
20158
20161
20175
20183
20193
20203
20211
20225
20252
20264

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
18
Phase 3
20
Phase 4
52
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 40 · Other 64

Bristol-Myers Squibb (24) · Sun Yat-sen University (6) · Yonsei University (5) · Hoffmann-La Roche (4) · Asan Medical Center (4) · Taipei Veterans General Hospital, Taiwan (3) · ShuGuang Hospital (3) · Nanfang Hospital, Southern Medical University (3)

Often tested with

Tested in the same studies.

Tenofovir (16) · Adefovir (8) · Lamivudine (7) · Peginterferon alfa-2a (4) · Tenofovir alafenamide (3) · Fuzheng huayu (3) · Tenofovir amibufenamide (2) · Ropeginterferon alfa-2b (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Entecavir is the comparator. A study of two new drugs counts under both.

  • 1Tucidinostat · Ou Bai, MD/PHD · next primary completion Sep 2029
Reaching primary completion within a year · 4, 1 in phase 3

Studies that test entecavir, phase 3 first.

Studies

Open first, then newest update. How each study uses entecavir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 104

See all 104 studies that test entecavir →

Given beside what is tested · 62 — entecavir is usual care or a partner of the new treatment

Showing 20 of 62.

As the comparator · 23 — what is tested is compared with entecavir

Showing 20 of 23.

Codes

What other systems call entecavir · ClinicalTrials.gg INT004266

  • MeSH (NLM) C413685entecavirConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 5968Y6H45MENTECAVIRConfirmed FDA, NLM, Wikidata
  • RxNorm 306266Confirmed FDA, Wikidata
  • Wikidata Q27126952entecavir hydrateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C65513EntecavirConfirmed FDA, Wikidata
  • DrugBank DBSALT001748One source Wikidata

Also registered as entecavir anhydrous (UNII NNU2O4609D · RxNorm 1546027).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.